1 Chen CJ, "genecity of high-arsenicartesian well water Multiple risk factors and related malignant neoplasm of blackfoot disease" 452-60, sclerosis1988
2 Everson RB, "dence in a prospective study" Scheinemachers DM 138-46, epidemiology1994
3 Chen GQ, "Use of arsenic trioxide (As2O3) in the treatment of acute promyeꠀlcytic leukemia(APL) I. As2O3 exerts dose- dependent dual effects on APL cells" 89 : 3345-3353, 1997
4 Soignet SL, "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemi" 19 : 3852-3860, 2001
5 Sun HD, "Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine" 12 : 170-1, 1992
6 Soriano AF, "Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines" 59 : 6178-6184, 1999
7 Shiff SJ, "Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenoꠀcarcinoma cells" 96 (96): 491-503, 1995
8 Klampfer L, "Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines" 93 : 2386-2394, 1999
9 Koki AT, "Potential utility of COX-2 inhibitors in chemopreꠀvention and chemotherapy" 8 : 1623-1638, 1999
10 Harris RE, "Nonsteroidal antiinflammatory drugs and breꠀast cancer" 7 : 203-205, 1996
1 Chen CJ, "genecity of high-arsenicartesian well water Multiple risk factors and related malignant neoplasm of blackfoot disease" 452-60, sclerosis1988
2 Everson RB, "dence in a prospective study" Scheinemachers DM 138-46, epidemiology1994
3 Chen GQ, "Use of arsenic trioxide (As2O3) in the treatment of acute promyeꠀlcytic leukemia(APL) I. As2O3 exerts dose- dependent dual effects on APL cells" 89 : 3345-3353, 1997
4 Soignet SL, "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemi" 19 : 3852-3860, 2001
5 Sun HD, "Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine" 12 : 170-1, 1992
6 Soriano AF, "Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines" 59 : 6178-6184, 1999
7 Shiff SJ, "Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenoꠀcarcinoma cells" 96 (96): 491-503, 1995
8 Klampfer L, "Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines" 93 : 2386-2394, 1999
9 Koki AT, "Potential utility of COX-2 inhibitors in chemopreꠀvention and chemotherapy" 8 : 1623-1638, 1999
10 Harris RE, "Nonsteroidal antiinflammatory drugs and breꠀast cancer" 7 : 203-205, 1996
11 Chan TA, "Mechanism underlying nonsteroidal antiinflammatory drug-mediated apoptosis" 95 : 681-686, 1998
12 Huang S, "Induction of mitosis-mediated apoptosis by sodium arseꠀnite in Hela S3 cells" 60 : 771-780, 2000
13 Zhang TC, "Induction of apoptosis and inhibition of huꠀman gastric cancer MGC-803 cell growth by arsenic trioxide" 35 : 1258-1263, 1999
14 Chen GQ, "In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leuꠀkemia: arsenic trioxide induces NB4 cell apoptosis with downregualation of Bcl-2 expression and modulation of PML-RAR/PML proteins" 88 : 1052-1061, 1996
15 Milas L, "Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme" 91 : 1501-1504, 1999
16 Duffy CP, "Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of NSAIDs" 34 : 1250-1259, 1998
17 Seol JG, "Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1" 265 : 400-404, 1999
18 Hida T, "Cyclooxyꠀgenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines" 6 : 2006-2011, 2000
19 Milas L, "Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse" 11 : 290-299, 2001
20 Torrance CJ, "Combinatorial chemoprevention of intestinal neoplasia" 6 : 1024-1028, 2000
21 Smalley WE, "Colorectal cancer and non-steroidal anti-inflammatory drugs" 39 : 1-20, 1997
22 Dannenberg AJ, "Chemoprevention of colon-rectal cancer through inhibition of cyclooxygenase-2" 26 : 499-504, 1999
23 Chen CJ, "Cancer potential in liver,lung,bladder and kidney due to ingested inorganic arsenic in drinking water" 66 : 888-92, 1992
24 Thun MJ, "Aspirin use and reduced risk of fatal colon cancer" 325 : 1593-6, 1991
25 Jung BH, "Arseꠀnic trioxide induces apoptosis of HL-60 cells via activation of intrinsic caspase protease with mitochondrial dysfunction" 34 : 308-315, 2002
26 Uslu R, "Arsenic trioꠀxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines" 6 : 4957-4964, 2000
27 Park WH, "Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibiꠀtor, p21, and apoptosis" 60 : 3065-3071, 2000
28 Ling YH, "Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines" 62 : 529-538, 2002
29 Shen ZY, "Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro" 4 : 33-37, 1999
30 Akao Y, "Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro" 445 : 59-62, 1992
31 Zheng J, "Arsenic trioxide incuces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression" 82 : 286-292, 1999
32 Cohen JJ, "Apoptosis:the physiologic pathway of cell death" 28 : 35-43, 1993
33 Williams GT, "Apoptosis in the immune system" 173 : 1-4, 1994